Publications by authors named "Zhefu Ma"

Claim this Profile
C
Comparative Efficacy of Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, and Neoadjuvant Chemo-Endocrine Therapy in Estrogen Receptor-Positive Breast Cancer Patients: A Meta-Analysis.
Yi Yuan, Ning Cui, Ziyi Xu, Chang Cui, Zongpeng Zhou, Zhefu Ma

Breast J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically predicted frailty index and risk of cutaneous melanoma: a two-sample Mendelian randomization study.
ZongPeng Zhou, Chang Cui, Yi Yuan, Zhefu Ma

Arch Dermatol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
Zhipeng Hong, Tao Liu, Lingfeng Wan, Pengyan Fa, Pankaj Kumar, Ayse S Yilmaz, Zhefu Ma

Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Lingfeng Wan, Tao Liu, Zhipeng Hong, You Pan, Steven T Sizemore, Zhefu Ma

Breast Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Xiaosong Yang, You Pan, Zhaojun Qiu, Zhanwen Du, Yao Zhang, Shanhuai Ma, Zhefu Ma

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress.
Yao Zhang, Jinzhi Lai, Zhanwen Du, Jinnan Gao, Shuming Yang, Zhefu Ma

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
Haoming Xia, Jianting Long, Ruifen Zhang, Xiaosong Yang, Zhefu Ma

Biomed Pharmacother· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTOR inhibitor rapamycin suppresses DNA double-strand break repair.
Honghong Chen, Zhefu Ma, Robert P Vanderwaal, Zhihui Feng, Ignacio Gonzalez-Suarez

Radiat Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disassembly of MDC1 foci is controlled by ubiquitin-proteasome-dependent degradation.
Wei Shi, Zhefu Ma, Henning Willers, Kamal Akhtar, Shaun P Scott

J Biol Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis.
Shannon L Gibson, Zhefu Ma, Leslie M Shaw

Cell Cycle· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
Zhefu Ma, Shannon L Gibson, Maura A Byrne, Junran Zhang, Morris F White

Mol Cell Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDC1 interacts with Rad51 and facilitates homologous recombination.
Junran Zhang, Zhefu Ma, Alejandro Treszezamsky, Simon N Powell

Nat Struct Mol Biol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of insulin receptor substrate 2 in mammary tumor metastasis.
Julie A Nagle, Zhefu Ma, Maura A Byrne, Morris F White, Leslie M Shaw

Mol Cell Biol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis